Loading company…
Petra Pharma Corp., based in New York, US, develops small molecule inhibitors for cancer and metabolic diseases.
Petra Pharma Corp., based in New York, US, develops small molecule inhibitors for the treatment of cancer and metabolic diseases. It was founded in 2015 and is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in